X

Clinical Trials

Contact Us

GU Cancer

EA8153 (NCT03419234)

Cabazitaxel with Abiraterone versus Abiraterone Alone:  A Randomized Trial for Extensive Disease in Prostate Cancer Following Docetaxel:  The CHAARTED2 Trial


NRG-GU005 (NCT03367702)

Phase III IGRT and SBRT versus IGRT and Hypofranctionated IMRT for Localized Intermediate Risk Prostate Cancer


A031501

Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation


MATCH: EAY131 (NCT02465050)

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.